911
Views
14
CrossRef citations to date
0
Altmetric
Review

Chemical Risk Factors of Primary Liver Cancer: An Update

, , , ORCID Icon &
Pages 179-188 | Published online: 05 Jan 2021

References

  • Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. doi:10.3322/caac.2149230207593
  • Howlander N, Noone AM, Krapcho M, et al. SEER cancer statistics review 1975–2016. Natl Cancer Inst. 2019.
  • Akinyemiju T, Abera S, Ahmed M, et al.; Collaboration GB of DLC. The burden of primary liver cancer and underlying etiologies from 1990 to 2015 at the global, regional, and national level: results from the global burden of disease study 2015. JAMA Oncol. 2017;3(12):1683–1691. doi:10.1001/jamaoncol.2017.3055.28983565
  • Ledda C, Loreto C, Zammit C, et al. Non-infective occupational risk factors for hepatocellular carcinoma: a review (Review). Mol Med Rep. 2017;15(2):511–533. doi:10.3892/mmr.2016.604628000892
  • Byrne CD, Targher G. NAFLD: a multisystem disease. J Hepatol. 2015;62(S1):S47–S64. doi:10.1016/j.jhep.2014.12.01225920090
  • Chalasani N, Younossi Z, Lavine JE, et al. The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association. Hepatology. 2012;55(6):2005–2023. doi:10.1002/hep.2576222488764
  • Petrick JL, Campbell PT, Koshiol J, et al. Tobacco, alcohol use and risk of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: the liver cancer pooling project. Br J Cancer. 2018;118(7):1005–1012. doi:10.1038/s41416-018-0007-z29520041
  • Dunn W, Angulo P, Sanderson S, et al. Utility of a new model to diagnose an alcohol basis for steatohepatitis. Gastroenterology. 2006;131(4):1057–1063. doi:10.1053/j.gastro.2006.08.02017030176
  • Dunn W, Shah VH. Pathogenesis of alcoholic liver disease. Clin Liver Dis. 2016;20(3):445–456. doi:10.1016/j.cld.2016.02.00427373608
  • Simon TG, Duberg AS, Aleman S, Chung RT, Chan AT, Ludvigsson JF. Association of aspirin with hepatocellular carcinoma and liver-related mortality. N Engl J Med. 2020;382(11):1018–1028. doi:10.1056/NEJMoa191203532160663
  • Wang S, Wan T, Ye M, et al. Nicotinamide riboside attenuates alcohol induced liver injuries via activation of SirT1/PGC-1α/mitochondrial biosynthesis pathway. Redox Biol. 2018;17:89–98. doi:10.1016/j.redox.2018.04.00629679894
  • Tanaka K, Tsuji I, Wakai K, et al. Cigarette Smoking and liver cancer risk: an evaluation based on a systematic review of epidemiologic evidence among Japanese. Jpn J Clin Oncol. 2006;36(7):445–456. doi:10.1093/jjco/hyl04016782973
  • U.S.DHSS. How Tobacco smoke causes disease the biology and behavioral basis for smoking-attributable disease a report of the surgeon general; 2010.
  • Liu Y, Wu F. Global burden of Aflatoxin-induced hepatocellular carcinoma: a risk assessment. Environ Health Perspect. 2010;118(6):818–824. doi:10.1289/ehp.090138820172840
  • Groopman JD, Wogan GN. Aflatoxin and hepatocellular carcinoma In: Penning TM, editor. Chemical Carcinogenesis. Totowa, NJ: Humana Press; 2011:113–133. doi:10.1007/978-1-61737-995-6_6
  • Ostry V, Malir F, Toman J, Grosse Y. Mycotoxins as human carcinogens—the IARC Monographs classification. Mycotoxin Res. 2017;33(1):65–73. doi:10.1007/s12550-016-0265-727888487
  • London WT, Petrick JL, McGlynn KA. Liver cancer In: Michael Thun, Martha S. Linet, James R. Cerhan, Christopher A. Haiman, and David Schottenfeld, editors. Schottenfeld and Fraumeni Cancer Epidemiology and Prevention, Fourth Edition; Published in the United States of America by Oxford University Press 198 Madison Avenue, New York, NY 10016, United States of America. 2017;637–638. doi:10.1093/oso/9780190238667.003.0033
  • Ross RK, Yu MC, Henderson BE, et al. Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet. 1992;339(8799):943–946. doi:10.1016/0140-6736(92)91528-G1348796
  • Autrup JL, Schmidt J, Seremet T, Autrup H. Determination of exposure to aflatoxins among Danish workers in animal feed production through the analysis of aflatoxin B1 adducts to serum albumin. Scand J Work Environ Health. 1991;17(6):436–440. doi:10.5271/sjweh.16831788537
  • Long XD, Ma Y, Zhou YF, et al. XPD codon 312 and 751 polymorphisms, and AFB1 exposure, and hepatocellular carcinoma risk. BMC Cancer. 2009;9(1). doi:10.1186/1471-2407-9-400
  • Degen GH. The challenge to assess workplace related risks from mycotoxin exposure. Mycotoxin Res. 2008;24(3):i–ii. doi:10.1007/BF03032336
  • Saad-Hussein A, Beshir S, Moubarz G, Elserougy S, Ibrahim MIM. Effect of occupational exposure to aflatoxins on some liver tumor markers in textile workers. Am J Ind Med. 2013;56(7):818–824. doi:10.1002/ajim.2216223359393
  • Viegas S, Veiga L, Malta-Vacas J, et al. Occupational exposure to aflatoxin (AFB1) in poultry production. J Toxicol Environ Health Part A. 2012;75(22–23):1330–1340. doi:10.1080/15287394.2012.721164
  • Sorenson WG, Simpson JP, Peach MJ, Thedell TD, Olenchock SA. Aflatoxin in respirable corn dust particles. J Toxicol Environ Health. 1981;7(3–4):669–672. doi:10.1080/152873981095300097288908
  • Villar S, Ortiz-Cuaran S, Abedi-Ardekani B, et al. Aflatoxin-induced TP53 R249S mutation in hepatocellular carcinoma in thailand: association with tumors developing in the absence of liver cirrhosis. PLoS One. 2012;7(6):e37707. doi:10.1371/journal.pone.003770722675488
  • Kirk GD, Lesi OA, Mendy M, et al. 249ser TP53 mutation in plasma DNA, hepatitis B viral infection, and risk of hepatocellular carcinoma. Oncogene. 2005;24(38):5858–5867. doi:10.1038/sj.onc.120873216007211
  • Uccello M, Malaguarnera G, Corriere T, Biondi A, Basile F, Malaguarnera M. Risk of hepatocellular carcinoma in workers exposed to chemicals. Hepat Mon. 2012;12(10). doi:10.5812/hepatmon.5943
  • Kapp R.W. Vinyl Chloride A2. In Encyclopedia of Toxicology: 3rd ed Oxford: Wexler P, Editor. Academic Press. 2014:934–938.
  • Mundt KA, Dell LD, Crawford L, Gallagher AE. Quantitative estimated exposure to vinyl chloride and risk of angiosarcoma of the liver and hepatocellular cancer in the US industry-wide vinyl chloride cohort: mortality update through 2013. Occup Environ Med. 2017;74(10):709–716. doi:10.1136/oemed-2016-10405128490663
  • Boffetta P, Matisane L, Mundt KA, Dell LD. Meta-analysis of studies of occupational exposure to vinyl chloride in relation to cancer mortality. Scand J Work Environ Health. 2003;29(3):220–229. doi:10.5271/sjweh.72512828392
  • Mastrangelo G, Fedeli U, Fadda E, et al. Increased risk of hepatocellular carcinoma and liver cirrhosis in vinyl chloride workers: synergistic effect of occupational exposure with alcohol intake. Environ Health Perspect. 2004;112(11):1188–1192. doi:10.1289/ehp.697215289165
  • Bolt HM. Vinyl chloride - A classical industrial toxicant of new interest. Crit Rev Toxicol. 2005;35(4):307–323. doi:10.1080/1040844049091597515989139
  • Sherman M. Vinyl chloride and the liver. J Hepatol. 2009;51(6):1074–1081. doi:10.1016/j.jhep.2009.09.01219836850
  • Lewis R, Rempala G, Dell LD, Mundt KA. Vinyl chloride and liver and brain cancer at a polymer production plant in Louisville, Kentucky. J Occup Environ Med. 2003. doi:10.1097/01.jom.0000058348.05741.1d
  • Mastrangelo G, Fedeli U, Fadda E, Milan G, Turato A, Pavanello S. Lung cancer risk in workers exposed to poly(vinyl chloride) dust: A nested case-referent study. Occup Environ Med. 2003;60(6):423–428. doi:10.1136/oem.60.6.42312771394
  • Hsieh HI, Chen PC, Wong RH, et al. Mortality from liver cancer and leukaemia among polyvinyl chloride workers in Taiwan: an updated study. Occup Environ Med. 2011;68(2):120–125. doi:10.1136/oem.2010.05697820798004
  • Weihrauch M, Benicke M, Lehnert G, Wittekind C, Wrbitzky R, Tannapfel A. Frequent k-ras-2 mutations and p16 INK4A methylation in hepatocellular carcinomas in workers exposed to vinyl chloride. Br J Cancer. 2001;84(7):982–989. doi:10.1054/bjoc.2000.167511286481
  • WHO. Exposure to arsenic: a major public health concern. Agriculture. 2010. doi:10.1016/j.ecoenv.2011.12.007
  • Marshall G, Ferreccio C, Yuan Y, et al. Fifty-year study of lung and bladder cancer mortality in Chile related to arsenic in drinking water. J Natl Cancer Inst. 2007;99(12):920–928. doi:10.1093/jnci/djm00417565158
  • Arsenic toxicity In: Encyclopedia of Metalloproteins; (2013) Arsenic Toxicity. In: Kretsinger RH, Uversky VN, Permyakov EA, editors. Encyclopedia of Metalloproteins Springer, New York, NY. 2013:120–125. doi:10.1007/978-1-4614-1533-6_100120
  • ATSDR - Environmental Medicine & Environmental Health Education - CSEM. Arsenic toxicity case study: what are the standards and regulation for arsenic exposure? Encycl Met. 2013. doi:10.1007/978-1-4614-1533-6_100120
  • Arteel GE. Hepatotoxicity In: Christopher States j, editor. Arsenic: Exposure Sources, Health Risks, and Mechanisms of Toxicity. John Wiley & Sons, Inc. 2015. 249–260. doi:10.1002/9781118876992.ch11
  • Liu J, Waalkes MP. Liver is a target of arsenic carcinogenesis. Toxicol Sci. 2008;105(1):24–32. doi:10.1093/toxsci/kfn12018566022
  • Palma-Lara I, Martínez-Castillo M, Quintana-Pérez JC, et al. Arsenic exposure: A public health problem leading to several cancers. Regul Toxicol Pharmacol. 2020;110:104539. doi:10.1016/j.yrtph.2019.10453931765675
  • Hong YS, Song KH, Chung JY. Health effects of chronic arsenic exposure. J Prev Med Public Health. 2014;47(5):245–252. doi:10.3961/jpmph.14.03525284195
  • Zhou Q, Xi S. A review on arsenic carcinogenesis: epidemiology, metabolism, genotoxicity and epigenetic changes. Regul Toxicol Pharmacol. 2018;99:78–88. doi:10.1016/j.yrtph.2018.09.01030223072
  • Jomova K, Jenisova Z, Feszterova M, et al. Arsenic: toxicity, oxidative stress and human disease. J Appl Toxicol. 2011;31(2):95–107. doi:10.1002/jat.164921321970
  • ATSDR. Case Studies in Environmental Medicine: Cadmium Toxicity. Atsdr; 2011.
  • Rani A, Kumar A, Lal A, Pant M. Cellular mechanisms of cadmium-induced toxicity: A review. Int J Environ Health Res. 2014;24(4):378–399. doi:10.1080/09603123.2013.83503224117228
  • Waalkes MP. Cadmium carcinogenesis. Mutat Res Fundam Mol Mech Mutagen. 2003;533(1–2):107–120. doi:10.1016/j.mrfmmm.2003.07.011
  • Arroyo VS, Flores KM, Ortiz LB, Gómez-Quiroz LE, Gutiérrez-Ruiz MC. Liver and cadmium toxicity. J Drug Metab Toxicol S 2012;55:S5–S001.
  • Huff J, Cirvello J, Haseman J, Bucher J. Chemicals associated with site-specific neoplasia in 1394 long-term carcinogenesis experiments in laboratory rodents. Environ Health Perspect. 1991;93:247–270. doi:10.1289/ehp.91932471773796
  • Campbell TC, Chen J, Liu C, Li J, Parpia B. Nonassociation of aflatoxin with primary liver cancer in a cross-sectional ecological survey in the People’s Republic of China. Cancer Res. 1990;50(21):6882–6893.2208157
  • Lynge E, Anttila A, Hemminki K. Organic solvents and cancer. Cancer Causes Control. 1997;8(3):406–419. doi:10.1023/A:10184614061209498902
  • Peters S, Glass DC, Greenop KR, et al. Childhood brain tumours: associations with parental occupational exposure to solvents. Br J Cancer. 2014;111(5):998–1003. doi:10.1038/bjc.2014.35824960405
  • Santibañez M, Vioque J, Alguacil J, et al. Occupational exposures and risk of pancreatic cancer. Eur J Epidemiol. 2010;25(10):721–730. doi:10.1007/s10654-010-9490-020640489
  • Chen R, Seaton A. A meta-analysis of mortality among workers exposed to organic solvents. Occup Med (Lond). 1996;46(5):337–344. doi:10.1093/occmed/46.5.3378918147
  • Campos-Outcalt D. Trichloroethylene: environmental and occupational exposure. Am Fam Physician. 1992;46(2):495–500.1636564
  • Lock EA, Reed CJ. Trichloroethylene: mechanisms of renal toxicity and renal cancer and relevance to risk assessment. Toxicol Sci. 2006;91(2):313–331. doi:10.1093/toxsci/kfj10716421178
  • Hansen J, Sallmén M, Seldén AI, et al. Risk of cancer among workers exposed to trichloroethylene: analysis of three Nordic cohort studies. J Natl Cancer Inst. 2013;105(12):869–877. doi:10.1093/jnci/djt10723723420
  • Zhou YC, Waxman DJ. Activation of peroxisome proliferator-activated receptors by chlorinated hydrocarbons and endogenous steroids. Environ Health Perspect. 1998;106 Suppl 4:983–988. doi:10.1289/ehp.98106s49839703482
  • Klaunig JE, Babich MA, Baetcke KP, et al. PPARalpha agonist-induced rodent tumors: modes of action and human relevance. Crit Rev Toxicol. 2003;33(6):655–780. doi:10.1080/71360837214727734
  • Jiang Y, Chen J, Tong J, Chen T. Trichloroethylene-induced gene expression and DNA methylation changes in B6C3F1 mouse liver. PLoS One. 2014;9(12):e116179. doi:10.1371/journal.pone.011617925549359
  • Dunlop MH, Dray E, Zhao W, et al. Mechanistic insights into RAD51-associated protein 1 (RAD51AP1) action in homologous DNA repair. J Biol Chem. 2012;287(15):12343–12347. doi:10.1074/jbc.C112.35216122375013
  • Gold LS, De Roos AJ, Waters M, Stewart P. Systematic literature review of uses and levels of occupational exposure to tetrachloroethylene. J Occup Environ Hyg. 2008;5(12):807–839. doi:10.1080/1545962080251086618949603
  • Yoshizawa K, Heatherly A, Malarkey DE, Walker NJ, Nyska A. A critical comparison of murine pathology and epidemiological data of TCDD, PCB126, and PeCDF. Toxicol Pathol. 2007;35(7):865–879. doi:10.1080/0192623070161851618098033
  • Hervé JC, Crump DLD, McLaren KK, et al. 2,3,4,7,8-pentachlorodibenzofuran is a more potent cytochrome P4501A inducer than 2,3,7,8-tetrachlorodibenzo-p-dioxin in herring gull hepatocyte cultures. Environ Toxicol Chem. 2010. doi:10.1002/etc.255
  • 15th International Multidisciplinary Scientific GeoConference SGEM 2015. www.sgem.org, SGEM2015 Conference Proceedings. 2015;1:647–654. Available from: https://www.sgem.org/SGEMLIB/spip.php?article6338.
  • Di Carlo FJ, Seifter J, DeCarlo VJ. Assessment of the hazards of polybrominated biphenyls. Environ Health Perspect. 1978;23:351–365. doi:10.1289/ehp.7823351209999
  • Troendle M, Wills BK. Chloral hydrate In: Philip Wexle, editor. Encyclopedia of Toxicology: Third Edition; Elsevier. 2014:833–834. doi:10.1016/B978-0-12-386454-3.00708-9
  • Calvert GM, Mehler LN, Alsop J, De Vries AL, Besbelli N. In: Krieger R, Doull J, Hodgson E, Maibach H, Reiter L, Ritter L, Ross J, Slikker W Jr., van Hemmen J, editors. Hayes' handbook of pesticide toxicology: 3rd edition; Boston, MA: Academic Press, 2010;2:1313–1369.
  • Osimitz TG, Lake BG. Mode-of-action analysis for induction of rat liver tumors by pyrethrins: relevance to human cancer risk. Crit Rev Toxicol. 2009;39(6):501–511. doi:10.1080/1040844090291401419463055
  • Holsapple MP, Pitot HC, Cohen SH, et al. Mode of action in relevance of rodent liver tumors to human cancer risk. Toxicol Sci. 2006;89(1):51–56. doi:10.1093/toxsci/kfj00116221960
  • Anwar WA, Khaled HM, Amra HA, El-Nezami H, Loffredo CA. Changing pattern of hepatocellular carcinoma (HCC) and its risk factors in Egypt: possibilities for prevention. Mutat Res Rev Mutat Res. 2008;659(1–2):176–184. doi:10.1016/j.mrrev.2008.01.005
  • US Department of Health Education and Welfare. Bioassays of DDT, TDE, and p,p’-DDE for Possible Carcinogenicity; 1978.
  • Clapp RW, Jacobs MM, Loechler EL. Environmental and occupational causes of cancer: new evidence 2005–2007. Rev Environ Health. 2008;23(1):1–38. doi:10.1515/reveh.2008.23.1.118557596
  • WHO. IARC Monographs evaluate DDT, lindane, and 2,4-D. Press Release, n.o 236.; 2015. doi:10.4185/RLCS-2016-1094en
  • Van Den Berg H. Global status of DDT and its alternatives for use in vector control to prevent disease. Environ Health Perspect. 2009;117(11):1656–1663. doi:10.1289/ehp.090078520049114
  • Bouwman H, van den Berg H, Kylin H. DDT and malaria prevention: addressing the paradox. Environ Health Perspect. 2011;119(6):744–747. doi:10.1289/ehp.100212721245017
  • Rogan WJ, Chen A. Health risks and benefits of bis(4-chlorophenyl)-1,1,1-trichloroethane (DDT). Lancet. 2005;366(9487):763–773. doi:10.1016/S0140-6736(05)67182-616125595
  • Harada T, Takeda M, Kojima S, Tomiyama N. Toxicity and carcinogenicity of dichlorodiphenyltrichloroethane (DDT). Toxicol Res. 2016;32(1):21–33. doi:10.5487/TR.2016.32.1.02126977256
  • McGlynn KA, Abnet CC, Zhang M, et al. Serum concentrations of 1,1,1-Trichloro-2,2-bis(p-chlorophenyl)ethane (DDT) and 1,1-Dichloro-2,2-bis(p-chlorophenyl)ethylene (DDE) and risk of primary liver cancer. J Natl Cancer Inst. 2006;98(14):1005–1010. doi:10.1093/jnci/djj26616849683
  • Persson EC, Graubard BI, Evans AA, et al. Dichlorodiphenyltrichloroethane and risk of hepatocellular carcinoma. Int J Cancer. 2012;131(9):2078–2084. doi:10.1002/ijc.2745922290210
  • Zhao B, Shen H, Liu F, et al. Exposure to organochlorine pesticides is an independent risk factor of hepatocellular carcinoma: A casecontrol study. J Expo Sci Environ Epidemiol. 2012. doi:10.1038/jes.2011.29
  • Daniel V, Huber W, Bauer K, Suesal C, Conradt C, Opelz G. Associations of Dichlorodiphenyltrichloroethane (DDT) 4.4 and Dichlorodiphenyldichloroethylene (DDE) 4.4 Blood Levels with Plasma IL-4. Arch Environ Health. 2002;57(6):541–547. doi:10.1080/0003989020960208612696651
  • Chaturvedi NK, Kumar S, Negi S, Tyagi RK. Endocrine disruptors provoke differential modulatory responses on androgen receptor and pregnane and xenobiotic receptor: potential implications in metabolic disorders. Mol Cell Biochem. 2010;345(1–2):291–308. doi:10.1007/s11010-010-0583-620830510
  • Robles H. Nitrosamines. In: Philip Wexler, editors. Encyclopedia of Toxicology: Third Edition; Academic Press. 2014:584–585. doi:10.1016/B978-0-12-386454-3.00523-6
  • Song P, Wu L, Guan W. Dietary nitrates, nitrites, and nitrosamines intake and the risk of gastric cancer: A meta-analysis. Nutrients. 2015;7(12):9872–9895. doi:10.3390/nu712550526633477
  • McElvenny DM, Mueller W, Ritchie P, et al. British rubber and cable industry cohort: 49-year mortality follow-up. Occup Environ Med. 2018;75(12):848–855. doi:10.1136/oemed-2017-10483430269103
  • Bolognesi C, Moretto A. Genotoxic risk in rubber manufacturing industry: a systematic review. Toxicol Lett. 2014;230(2):345–355. doi:10.1016/j.toxlet.2013.11.01324275385
  • Li H, Jönsson BAG, Lindh CH, Albin M, Broberg K. N-nitrosamines are associated with shorter telomere length. Scand J Work Environ Health. 2011;37(4):316–324. doi:10.5271/sjweh.315021321788
  • Tolba R, Kraus T, Liedtke C, Schwarz M, Weiskirchen R. Diethylnitrosamine (DEN)-induced carcinogenic liver injury in mice. Lab Anim. 2015;49(1_suppl):59–69. doi:10.1177/002367721557008625835739
  • Mitacek EJ, Brunnemann KD, Hoffmann D, et al. Volatile nitrosamines and tobacco-specific nitrosamines in the smoke of Thai cigarettes: a risk factor for lung cancer and a suspected risk factor for liver cancer in Thailand. Carcinogenesis. 1999;20(1):133–137. doi:10.1093/carcin/20.1.1339934860
  • Mitacek EJ, Brunnemann KD, Suttajit M, et al. Exposure to N-nitroso compounds in a population of high liver cancer regions in Thailand: volatile nitrosamine (VNA) levels in Thai food. Food Chem Toxicol. 1999;37(4):297–305. doi:10.1016/S0278-6915(99)00017-410418946
  • Socas L, Zumbado M, Pérez-Luzardo O, et al. Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med. 2005;39(5):e27LP–e27. doi:10.1136/bjsm.2004.01359915849280
  • An N. Oral contraceptives use and liver cancer risk: a dose-response meta-analysis of observational studies. Medicine (Baltimore). 2015;94(43):e1619. doi:10.1097/MD.000000000000161926512555
  • Pilati C, Letouzé E, Nault JC, et al. Genomic profiling of hepatocellular adenomas reveals recurrent FRK-activating mutations and the mechanisms of malignant transformation. Cancer Cell. 2014;25(4):428–441. doi:10.1016/j.ccr.2014.03.00524735922
  • Micchelli STL, Vivekanandan P, Boitnott JK, Pawlik TM, Choti MA, Torbenson M. Malignant transformation of hepatic adenomas. Mod Pathol. 2008;21(4):491–497. doi:10.1038/modpathol.2008.818246041
  • Hardt A, Stippel D, Odenthal M, Hölscher AH, Dienes H-P, Drebber U. Development of hepatocellular carcinoma associated with anabolic androgenic steroid abuse in a young bodybuilder: a case report. Case Rep Pathol. 2012;2012:1–5. doi:10.1155/2012/195607
  • Solbach P, Potthoff A, Raatschen HJ, et al. Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: A case report. BMC Gastroenterol. 2015;15. doi:10.1186/s12876-015-0288-0
  • Chen C-J, Yang Y-H, Lin M-H, et al. Herbal medicine containing aristolochic acid and the risk of primary liver cancer in patients with hepatitis C virus infection. Cancer Epidemiol Biomarkers Prev. 2019;28(11):1876–1883. doi:10.1158/1055-9965.EPI-19-002331409611